HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tatyana Korontsvit Selected Research

Tatyana Korontsvit Research Topics

Disease

22Neoplasms (Cancer)
12/2023 - 02/2004
7Leukemia
06/2017 - 08/2007
6Wilms Tumor (Wilm's Tumor)
12/2023 - 08/2007
3Bites and Stings (Sting)
11/2023 - 10/2015
3Ovarian Neoplasms (Ovarian Cancer)
11/2023 - 05/2021
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2023 - 07/2010
2Ovarian Epithelial Carcinoma
11/2023 - 05/2023
2Melanoma (Melanoma, Malignant)
08/2020 - 06/2017
2Mesothelioma
10/2010 - 08/2007
2Malignant Mesothelioma
10/2010 - 08/2007
2Hypersensitivity (Allergy)
07/2010 - 02/2004
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2005 - 02/2004
1Hematologic Neoplasms (Hematological Malignancy)
12/2023
1Ascites
05/2021
1Testicular Neoplasms (Testicular Cancer)
06/2017
1Thoracic Neoplasms
10/2010
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2010
1Pathologic Complete Response
07/2010
1Lymphoma (Lymphomas)
12/2005
1B-Cell Lymphoma (Lymphoma, B Cell)
12/2005
1Philadelphia Chromosome
02/2004

Drug/Important Bio-Agent (IBA)

14Peptides (Polypeptides)IBA
05/2021 - 02/2004
12AntigensIBA
12/2023 - 10/2005
6EpitopesIBA
11/2023 - 08/2007
5Proteins (Proteins, Gene)FDA Link
01/2022 - 10/2005
5Oncogene Proteins (Oncogene Protein)IBA
01/2017 - 08/2007
4T-Cell Antigen Receptors (T-Cell Receptor)IBA
12/2023 - 10/2015
4WT1 ProteinsIBA
12/2023 - 08/2007
4HLA-A Antigens (HLA-A)IBA
01/2022 - 08/2014
4Transcription Factors (Transcription Factor)IBA
03/2013 - 08/2007
4VaccinesIBA
07/2011 - 02/2004
4Protein Subunit VaccinesIBA
07/2010 - 02/2004
3Chimeric Antigen ReceptorsIBA
12/2023 - 05/2023
3Neoplasm Antigens (Tumor Antigens)IBA
11/2023 - 01/2017
3Interferon-gamma (Interferon, gamma)IBA
10/2010 - 02/2004
2RMFPNAPYLIBA
11/2023 - 05/2023
2HLA-A2 Antigen (HLA A2 Antigen)IBA
11/2023 - 05/2023
2HLA Antigens (Human Leukocyte Antigens)IBA
05/2021 - 12/2019
2LigandsIBA
05/2021 - 12/2019
2Histocompatibility Antigens Class IIBA
12/2019 - 01/2008
2AntibodiesIBA
06/2017 - 08/2014
2Monoclonal AntibodiesIBA
10/2015 - 08/2014
2EnzymesIBA
08/2007 - 02/2004
1PhosphopeptidesIBA
01/2022
1RNA (Ribonucleic Acid)IBA
05/2021
1Actinium-225IBA
08/2020
1Antineoplastic Agents (Antineoplastics)IBA
08/2020
1Melanocyte-Stimulating Hormones (MSH)IBA
08/2020
1Radioisotopes (Radionuclides)IBA
08/2020
1Silicon Dioxide (Silica)FDA LinkGeneric
08/2020
1Type 1 Melanocortin ReceptorIBA
08/2020
1Phosphotransferases (Kinase)IBA
12/2019
1Immunoglobulin G (IgG)IBA
07/2011
1Carbon Nanotubes (Carbon Nanotube)IBA
07/2011
1CytokinesIBA
10/2010
1HLA-DR Antigens (HLA-DR)IBA
08/2009
1Cyclin D1IBA
08/2009
1HLA-DRB1 Chains (HLA DRB1)IBA
08/2007
1Interleukin-18 (Interleukin 18)IBA
12/2005
1InterferonsIBA
02/2004
1Interferon-alpha (Interferon Alfa)IBA
02/2004
1Imatinib Mesylate (Gleevec)FDA Link
02/2004

Therapy/Procedure

5Immunotherapy
05/2021 - 08/2007
3Therapeutics
12/2023 - 07/2010
1Cell- and Tissue-Based Therapy (Cell Therapy)
10/2015
1Transplantation
02/2004
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
02/2004